1. The dawn of a new Era: mRNA vaccines in colorectal cancer immunotherapy
   Jingjing Song et al, 2024, International Immunopharmacology CrossRef
2. Cancer testis antigens: Emerging therapeutic targets leveraging genomic instability in cancer
   Adviti Naik et al, 2024, Molecular Therapy: Oncology CrossRef
3. Prediction and identification of HLA-A*0201-restricted epitopes from cancer testis antigen CT23
   Xia Zeng et al, 2023, Human Vaccines & Immunotherapeutics CrossRef
4. An Engineered M13 Filamentous Nanoparticle as an Antigen Carrier for a Malignant Melanoma Immunotherapeutic Strategy
   Nuša Brišar et al, 2024, Viruses CrossRef
5. Neoantigens and cancer-testis antigens as promising vaccine candidates for triple-negative breast cancer: Delivery strategies and clinical trials
   RamaRao Malla et al, 2024, Journal of Controlled Release CrossRef
6. The use of xenogenic testicular antigens for induction of antitumor reactions
   G. V. Seledtsova et al, 2024, Siberian journal of oncology CrossRef
7. Melanoma Antigen Family A (MAGE A) as Promising Biomarkers and Therapeutic Targets in Bladder Cancer
   Shiv Verma et al, 2024, Cancers CrossRef
8. Machine Learning for Early Discrimination Between Lung Cancer and Benign Nodules Using Routine Clinical and Laboratory Data
   Wei Wei et al, 2024, Annals of Surgical Oncology CrossRef